Premium
Differential control by arterial and portal noradrenaline of hepatic carbohydrate metabolism: Evidence for an indirect hemodynamic mechanism
Author(s) -
Miura Hisayuki,
Jungermann Kurt,
Gardemann Andreas
Publication year - 1993
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.1840180620
Subject(s) - hemodynamics , mechanism (biology) , carbohydrate metabolism , medicine , metabolism , cardiology , epistemology , philosophy
In an earlier study it was found (a) that arterial noradrenaline caused increases in glucose and lactate output slower in onset, smaller in peak height and clearly longer in duration than those caused by portal noradrenaline and (b) that arterial noradrenaline was extracted to a much greater extent than portal noradrenaline. It is possible that the differences in the actions of arterial and portal noradrenaline were due to the different hemodynamic changes; arterial noradrenaline reduced hepatic flow more strongly and with different kinetics than did portal noradrenaline. Therefore the effects of arterial and portal noradrenaline were investigated in isolated rat liver, singlepass perfused through both the hepatic artery (100 cm H 2 O, 30% flow) and the portal vein (15 cm H 2 O, 70% flow), after inhibition of the hemodynamic alterations by the Ca 2+ antagonist nifedipine. We found (a) that nifedipine inhibited the hemodynamic changes by arterial noradrenaline strongly and those by portal noradrenaline slightly, (b) that the remaining hemodynamic alterations in the presence of high concentrations of the Ca 2+ antagonist (100 μmol/L)–slight decrease in portal flow with unaffected arterial flow– were essentially identical after arterial and portal application of noradrenaline, (c) that the pronounced kinetic differences in the alterations by arterial and portal noradrenaline of glucose and lactate balance were diminished by 50 μmol/L nifedipine and abolished by 100 μmol/L of the Ca 2+ antagonist and (d) that the different hepatic extractions of arterial and portal noradrenaline were greatly reduced and almost equalized by nifedipine. These observations allow the conclusion that the differences in the metabolic changes by arterial and portal noradrenaline were caused indirectly by the pronounced differences in the hemodynamic altercations after arterial and portal application of this catecholamine. They confirm earlier morphological and biochemical observations that, in principle, arterial and portal blood reach similar areas of liver parenchyma. (HEPATOLOGY 1993;18:1410–1415.)